This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.With the excitement of the scientific landscape, in such areas as genomics, regenerative medicine, aging and the mind, there has never been a more favorable time to harness the opportunity to re-engineer a center, accelerate discoveries and foster education which will improve health. Scripps has responded to this backdrop and charge with a creative infrastructure that is intended to achieve transformation employing innovative strategies to hybridize the basic and clinical programs and unprecedented institutional commitments. The Scripps Translational Science Institute (STSI) will emphasize three dimensions of translation: (1) traditional , bench to bedside, (2) bedside to bench and back to bedside, and (3) bedside to the community and practice of medicine. STSI exploits the excitement of today's scientific advances to catapult tomorrow's preventions,. betterment of health, and the training of the future leaders of academic medicine. The vision of our program provides the appropriate amalgam of 'integration and innovation,' and the remarkable opportunity to capitalize on particular strengths at The Scripps Research Institute (TSRI), the largest biomedical research institute in the United States, and partnering institutions and faculty that have led to the development of 4 over-arching goals of the STSI (the 4 Ts').(1) Ignite the spirit of discovery of highlyrcharged interdisciplinary research, coupling translational, clinical and community-based investigation'(2) Inspire trainees . and young faculty through innovative curriculum and learning experiences, promoting not only scientific productivity but dedicated translational research and education career paths; (3) Integrate the efforts at TSRI and Scripps Health and partnering institutions in the community by building on existing programs, in the pursuit I of unprecedented engagement of the population of San Diego; and (4) Infrastructure and informatics buildup to ': potentiate and accelerate the ambitious needs of the program. Parallel to the outstanding NCRR and overall | NIH support to Scripps, the Scripps Health system has provided a massive, unprecedented investment that fully | certifies its priority and willingness to take on risk to promote heightened academic transformation. Building j upon and establishing genuine, specific collaborations with leading translational science investigators in a 0.5 mile hub on N, Torrey Pines Rd has greatly enriched the academic capabilities for STSI's success. Furthermore, collaborations with a large subset of the 550 life science companies in San Diego provide an , extraordinary advantage for accessing innovative technology and catalyzing patient benefitSan Diego's rich life science has truly been galvanized by STSI. By virtue of the re-engineered infrastructure and enhanced plasticity, STSI is perfectly poised to access the very large and diverse San Diego population through its dominant health care system and well established community education and research programs that have consistently focused on under-represented minorities. STSI will have a substantive impact on improving medicine and training physician-investigator leaders for the future.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1RR025774-01
Application #
7719864
Study Section
Special Emphasis Panel (ZRR1-SRC (99))
Project Start
2008-05-19
Project End
2009-04-30
Budget Start
2008-05-19
Budget End
2009-04-30
Support Year
1
Fiscal Year
2008
Total Cost
$468,099
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Liu, Wendy; Outlaw, Jessica J; Wineinger, Nathan et al. (2018) Effect of co-payment on behavioral response to consumer genomic testing. Transl Behav Med 8:130-136
Grogan, Shawn P; Duffy, Stuart F; Pauli, Chantal et al. (2018) Gene expression profiles of the meniscus avascular phenotype: A guide for meniscus tissue engineering. J Orthop Res 36:1947-1958
Baek, Jihye; Sovani, Sujata; Choi, Wonchul et al. (2018) Meniscal Tissue Engineering Using Aligned Collagen Fibrous Scaffolds: Comparison of Different Human Cell Sources. Tissue Eng Part A 24:81-93
Lo Sardo, Valentina; Chubukov, Pavel; Ferguson, William et al. (2018) Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing. Cell 175:1796-1810.e20
Dudas, Gytis; Carvalho, Luiz Max; Bedford, Trevor et al. (2017) Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature 544:309-315
McCurley, Jessica L; Penedo, Frank; Roesch, Scott C et al. (2017) Psychosocial Factors in the Relationship between Socioeconomic Status and Cardiometabolic Risk: the HCHS/SOL Sociocultural Ancillary Study. Ann Behav Med 51:477-488
Rueda, Manuel; Torkamani, Ali (2017) SG-ADVISER mtDNA: a web server for mitochondrial DNA annotation with data from 200 samples of a healthy aging cohort. BMC Bioinformatics 18:373
Jones, Marilyn C; Topol, Sarah E; Rueda, Manuel et al. (2017) Mutation of WIF1: a potential novel cause of a Nail-Patella-like disorder. Genet Med 19:1179-1183
Rueda, Manuel; Wagner, Jennifer L; Phillips, Tierney C et al. (2017) Molecular Autopsy for Sudden Death in the Young: Is Data Aggregation the Key? Front Cardiovasc Med 4:72
Lo Sardo, Valentina; Ferguson, William; Erikson, Galina A et al. (2017) Influence of donor age on induced pluripotent stem cells. Nat Biotechnol 35:69-74

Showing the most recent 10 out of 204 publications